2nd June 2022 | Pharma Updates - PharmaState Academy

PharmaState Updates – Latest Pharma Happenings

PharmaLytica Expo contribute to pharmaceutical industry's $130 billion growth story by 2030

The eighth edition of the PharmaLytica Expo welcomed industry professionals yesterday. The three-day annual exhibition offers business matchmaking and networking opportunities for all industry professionals, including pharma leaders among others.

Preeti Futnani appointed as General Manager, Vaccines at Sanofi India

Sanofi India announced the appointment of Preeti Futnani as the company’s General Manager- Vaccines on Wednesday. Futnani joins Sanofi from the Greater Gulf MCO, where she was the franchise head for Dupixent Dermatology.

Manufacturing sops in green energy, pharma, and battery sectors will increase capex: ICRA report

With overwhelming responses to the government’s production-linked incentives, capital expenditure in the manufacturing sector is on track to increase schemes, particularly for the lithium-ion battery, pharmaceutical, and solar module sectors

Pfizer to exit GSK's consumer health arm following its spin-off

Pfizer’s board nominees, according to GSK’s latest statement, would remain even if the US drugmaker planned to sell up, though GSK said Pfizer would exit in a “disciplined manner. ” GSK also stated that it intends to “disciplined” monetize its Haleon stake.

Medtronic introduced CE-marked flow diverter for endovascular treatment of brain aneurysms

Medtronic India has introduced the Pipeline Vantage with Shield Technology, a CE-marked fourth-generation flow diverter for endovascular treatment of brain aneurysms.

Sun Pharma anticipates high single-digit top-line growth in FY23

Sun Pharma expects high single-digit top-line growth in the current fiscal year, with all of its business verticals leading the charge. The company, which had revenues of Rs 38,426 crore in FY22, plans to invest 7-8% of sales in R&D in the current fiscal.

NTAGI may soon conduct a review of the efficacy data for India's first intranasal Covid vaccine

The National Technical Advisory Group on Immunisation (NTAGI) is expected to meet this month to review the safety and efficacy data of India’s first intranasal Covid-19 vaccine, developed by Hyderabad-based Bharat Biotech.